Summary Of: Combivir

Encyclodia Page On: Combivir

These Are Links To Other Documents

Lamivudine | reverse transcriptase inhibitor | Zidovudine | reverse transcriptase inhibitor | CAS number | ATC code | J05 | PubChem | Pregnancy cat. | US | Legal status | POM | UK | ℞-only | US | Routes | HIV infection | fixed dose combination | antiretroviral drugs | lamivudine | zidovudine | pill burden | reverse transcriptase inhibitors | enzyme | reverse transcriptase | viral load | CD4 cell | Food and Drug Administration | GlaxoSmithKline | v | d | Antivirals | HIV | HAART | J05 | Nucleoside & Nucleotide Reverse Transcriptase Inhibitors (NRTI) | Abacavir (ABC) | Emtricitabine (FTC) | KP-1461 | Lamivudine (3TC) | Tenofovir | Didanosine (ddI) | Zidovudine (AZT) | Apricitabine | Stampidine | Elvucitabine | Racivir | Amdoxovir | Stavudine (d4T) | Zalcitabine (ddC) | Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTI) | Efavirenz | Nevirapine | Etravirine | Rilpivirine | Loviride | Delavirdine | Protease Inhibitors (PI) | Atazanavir | Brecanavir | Fosamprenavir | Lopinavir | Darunavir | Nelfinavir | Ritonavir | Saquinavir | Tipranavir | Amprenavir | Indinavir | Entry/fusion inhibitors | Aplaviroc | Enfuvirtide | Maraviroc | Vicriviroc | PRO 140 | Ibalizumab | Integrase inhibitors | Raltegravir | Elvitegravir | Maturation inhibitors | Bevirimat | Vivecon | Combined formulations | Atripla | Trizivir | Truvada | Kaletra | Epzicom | Abzyme | Calanolide A | Ceragenin | Cyanovirin-N | Diarylpyrimidines | Epigallocatechin gallate (EGCG) | Foscarnet | Globoidnan A | Griffithsin | Hydroxyurea | Miltefosine | Portmanteau inhibitors | Seliciclib | Synergistic enhancers | Tre recombinase | Zinc finger protein transcription factor | DHHS | first-line agent | clinical trials | FDA | Development | | medical treatment | stub | help | Categories | Medical treatment stubs | Fixed dose combination (antiretroviral) |